Haemonetics | HAE - Selling And Administration Expenses


Haemonetics reported $118.94M in Selling and Administration Expenses for its fiscal quarter ending in June of 2026.





Selling And Administration Expenses Change Date
Baxter International USD 735M 7M Jun/2026
Becton, Dickinson and Co. USD 1.26B 48M Jun/2026
Boston Scientific USD 1.8B 22M Jun/2026
Cerus USD 19.33M 1.55M Dec/2024
Cooper Companies USD 401.3M 274.9M Jun/2026
Fresenius EUR 760M 17M Jun/2026
Fresenius Medical Care EUR 736.01M 12.99M Jun/2026
Globus Medical USD 286.82M 10.95M Jun/2026
Haemonetics USD 118.94M 1.99M Jun/2026
ICU Medical USD 151.92M 2.64M Jun/2026
Intuitive Surgical USD 1.08B 465.5M Sep/2026
Medtronic 3.2B 141M Jun/2026
Merit Medical Systems USD 129.23M 18.76M Jun/2026
Neogen USD 100.8M 1000K Jun/2026
OraSure Technologies USD 13.21M 3.29M Dec/2025
Plus Therapeutics USD 4.26M 779K Mar/2026
Quidel USD 189.7M 9.6M Jun/2026
ResMed USD 290.65M 10.86M Jun/2026
STAAR Surgical USD 45.14M 6.5M Jun/2026
Steris USD 369.7M 17.9M Jun/2026
Stryker USD 2.12B 32M Jun/2026
Teleflex USD 213.52M 12.5M Jun/2026
Terumo JPY 109.7B 5.11B Jun/2026
Thermo Fisher Scientific USD 1.86B 46M Sep/2026
US Physical Therapy USD 19M 731K Jun/2026
Zimmer Biomet Holdings USD 911.6M 61.7M Jun/2026